Related Experiment Video
Updated: Jul 31, 2025

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional
We developed SPEEDi-CRISPR, a novel CRISPR-Cas12a diagnostic assay. This dual-function approach enhances sensitivity for infectious disease detection without pre-amplification, offering a pragmatic solution for resource-limited settings.
Area of Science:
- Molecular Biology
- Biotechnology
- Diagnostics
Background:
- CRISPR-based biosensing offers next-generation diagnostics for infectious diseases, particularly for point-of-care (POC) testing.
- Current CRISPR assays often rely on a single Cas12a/Cas13a function and require pre-amplification, limiting their efficiency in resource-limited settings.
Conclusions:
- The dual-function strategy of CRISPR-Cas12a offers a new paradigm for developing next-generation CRISPR diagnostics.
- The SPEEDi-CRISPR assay provides a sensitive, specific, and pre-amplification-free tool for POC infectious disease testing, suitable for resource-limited areas.
More Related Videos
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
The Antiviral System of Bacteria and Archaea: CRISPR